FDA seeks comments on medical-imaging guidance

10/13/2008 | HealthImaging.com

The FDA is accepting public comments on a draft guidance for makers of medical-imaging drugs and devices that provide contrast enhancement. The guidance focuses on developing contrast indications for imaging devices that use approved drugs or biological products. It also contains recommendations to promote the timely and effective evaluation and regulation of imaging drugs and devices.

View Full Article in:

HealthImaging.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Program Coordinator/Lecturer for the Regulatory Science program
Johns Hopkins University
Washington, DC
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA